COMMUNIQUÉS West-GlobeNewswire

Auxly Announces Listing of Warrants
27/07/2018
VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (the " Company ") is pleased to announce that it has received the approval of the TSX Venture Exchange (" TSXV ") [...]
CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center
27/07/2018
Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing [...]
Status of Orphan designation of Apealea in the European Union
27/07/2018
Oasmia Pharmaceutical AB (NASDAQ: OASM) herewith announces that Apealea was designated as an orphan medicine by the European Commission in 2006 and alongside the procedure of the application for assessing a Market [...]
Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key Clinical Programs
27/07/2018
LONDON, July 27, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) today announces its unaudited financial results for the six months ended June 30, 2018 and updates [...]
DBV Technologies Reports June 30, 2018 Cash Position
27/07/2018
Montrouge, France, July 27, 2018 DBV Technologies Reports June 30, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as of [...]
DBV Technologies publie sa position de trésorerie au 30 Juin 2018
27/07/2018
Montrouge, France, le 27 Juillet (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 30 Juin 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]
Lefebvre family inspired by Terry Fox while walking across Canada for cancer research
27/07/2018
HALLVILLE, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- On May 1, Jimmy Lefebvre and his family left his parents’ home in Grande Prairie, Alberta to embark on a 5,700-kilometre walk across Canada in honour of his late [...]
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million
27/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering of 18,181,818 ordinary shares at a [...]
Scythian Biosciences Announces Director Resignation
27/07/2018
TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]
Adherium Receives Additional U.S. FDA 510(k) Clearance, Setting in Motion a Full U.S. Consumer Launch of the Hailie™ Solution
27/07/2018
SAN MATEO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health platform that improves medication adherence, patient outcomes and engagement, today announced the U.S. Food and [...]
National Research Corporation to Broadcast its 2018 Second Quarter Conference Call Live on the Internet
26/07/2018
Lincoln, Nebraska, July 26, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 second quarter earnings conference call on [...]
Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018
26/07/2018
JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]
Bioblast Pharma Ltd. Corporate and Management Update
26/07/2018
TEL AVIV, Israel and NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN) is providing an update on business development activities as well as notice of an organization change that affects [...]
ContraFect Corporation Announces Proposed Public Offering of Common Stock
26/07/2018
YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]
Intercept to Announce Second Quarter 2018 Financial Results on August 2, 2018 and Present at Upcoming Investor Conference
26/07/2018
NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
26/07/2018
MEDFORD, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced the Company plans to participate in the upcoming Canaccord [...]
Dova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018
26/07/2018
DURHAM, N.C., July 26, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Thursday, August 9, 2018 at 4:30 p.m. ET to discuss second quarter 2018 financial results and [...]
electroCore, Inc. to Report Second Quarter Financial Results on August 13, 2018
26/07/2018
BASKING RIDGE, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]
Loop Industries Expands Into Cosmetics Sector With L’Oréal Group
26/07/2018
TERREBONNE, Quebec, July 26, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP), a global leader in sustainable packaging innovation, announced that it has signed a Letter of Intent with L’Oréal Group, the [...]

Pages